Contact Us


Your Name (required)

Your Email (required)

Subject

Your Message

News and Resources

No Room For Error: Avoid These Six Reasons For Bulk Pharmaceutical Returns

A version of this story was published on DC Velocity in July 2017 – View it here. Companies within the pharmaceutical supply chain must consistently deliver the correct product at the right time to the proper person.  Patient lives depend on the efficient collaboration between manufacturers, wholesalers, logistics service providers and dispensers. Stakes are equally high when products are removed from sale or prevented from entering the commercial market.  There is no room for error whe...

White Paper – Serialization Implementation and Operations for DSCSA Compliance

SUMMARY With the stroke of a pen in 2013, the pharmaceutical industry mobilized in order to comply with sweeping changes enacted by the Drug Quality and Safety Act. The Law includes the Drug Supply Chain Security Act (“DSCSA”), written to increase patient safety by minimizing risk from unauthorized pharmaceutical drug products entering the marketplace.   The Federal Drug Administration, charged with enforcing the Act, set deadlines for the industry to comply with this law. The law requires...

WDSrx In The News – Pharmaceutical Commerce

Editor Nick Basta wrote in Pharmaceutical Commerce about WDSrx packaging and labeling programs that serialize product being utilized by small and mid-size pharmaceutical manufacturers to stay in business after the November 27, 2017 deadline. Smaller manufacturers with either a limited number of products, or a product volume too small to economically justify installing a DSCSA-compliant packaging line, now have another option.  Read the full story here....

Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.